Phosphoramidites

2'-Modified Phosphoramidites
(466/466)
2'-Phosphoramidites
(21/21)
3'-Modified Phosphoramidites
(186/186)
5'-Modified Phosphoramidites
(21/21)
Arabino Phosphoramidites
(19/19)
Base Protected Phosphoramidites (365/365) Dye Phosphoramidites
(53/53)
Label Phosphoramidites
(82/82)
Linker Phosphoramidites
(72/72)
Other Phosphoramidites
(92/92)
PMO Phosphoramidates and Derivatives (33/33) PseudoUridine Phosphoramidite
(12/12)
Reverse Phosphoramidites
(15/15)
Spacer Phosphoramidites
(22/22)
Backbone
Modification
Base Type
Filtered by
Clear All

DMTr-2'-O-MOE-rA(Bz)-3'-((2-cyanoethoxy)(diisopropylamino) phosphoramidite)-ethyl-diisopropylphosphoramidite

Description: DMTr-2'-O-MOE-rA(Bz)-3'-((2-cyanoethoxy)(diisopropylamino) phosphoramidite)-ethyl-diisopropylphosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified adenosine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as RNA interference (RNAi), gene silencing, and nucleic acid therapeutics.
CAT: BRP-00581
MF: C58H76N8O11P2
MF: 1123.24
Purity: ≥93%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: PAPVZRWLBSUSMQ-SXPYXJKBSA-N
IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl (2-(((2-cyanoethoxy)(diisopropylamino)phosphaneyl)oxy)ethyl) diisopropylphosphoramidite
InChI: InChI=1S/C58H76N8O11P2/c1-40(2)65(41(3)4)78(73-32-18-31-59)74-35-36-75-79(66(42(5)6)43(7)8)77-52-50(37-72-58(45-21-16-13-17-22-45,46-23-27-48(69-10)28-24-46)47-25-29-49(70-11)30-26-47)76-57(53(52)71-34-33-68-9)64-39-62-51-54(60-38-61-55(51)64)63-56(67)44-19-14-12-15-20-44/h12-17,19-30,38-43,50,52-53,57H,18,32-37H2,1-11H3,(H,60,61,63,67)/t50-,52-,53-,57-,78?,79?/m1/s1

DMTr-2'-O-MOE-rG(iBu)-3'-(L)-PSM-Phosphoramidite

Description: DMTr-2'-O-MOE-rG(iBu)-3'-(L)-PSM-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified guanosine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as antisense technology, RNA interference (RNAi), and gene regulation research.
CAT: BRP-00582
CAS: 2379296-19-0
MF: C50H57N6O12PS
MF: 997.07
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: BIELQCFHRDHWIK-VZEHQRRASA-N
CanonicalSMILES: O=C1N=C(NC(=O)C(C)C)NC2=C1N=CN2C3OC(COC(C=4C=CC=CC4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)C(OP7OC(CS(=O)(=O)C=8C=CC=CC8)C9N7CCC9)C3OCCOC
IUPAC Name: N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2-methoxyethoxy)-4-(((1S,3S,3aS)-3-((phenylsulfonyl)methyl)tetrahydro-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl)oxy)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
InChI: InChI=1S/C50H57N6O12PS/c1-32(2)46(57)53-49-52-45-42(47(58)54-49)51-31-55(45)48-44(64-28-27-61-3)43(68-69-56-26-12-17-39(56)41(67-69)30-70(59,60)38-15-10-7-11-16-38)40(66-48)29-65-50(33-13-8-6-9-14-33,34-18-22-36(62-4)23-19-34)35-20-24-37(63-5)25-21-35/h6-11,13-16,18-25,31-32,39-41,43-44,48H,12,17,26-30H2,1-5H3,(H2,52,53,54,57,58)/t39-,40+,41+,43+,44+,48+,69+/m0/s1
Synonyms: Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-3'-O-[(1S,3S,3aS)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]-

DMTr-2'-O-MOE-rG(dmf)-3'-(L)-PSM-Phosphoramidite

Description: DMTr-2'-O-MOE-rG(dmf)-3'-(L)-PSM-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified guanosine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as antisense technology, RNA interference (RNAi), and gene regulation research.
CAT: BRP-00583
MF: C49H56N7O11PS
MF: 982.06
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: KSGZFWPZSAYMSD-FSWBDJQRSA-N
IUPAC Name: N'-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2-methoxyethoxy)-4-(((1S,3S,3aS)-3-((phenylsulfonyl)methyl)tetrahydro-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl)oxy)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide
InChI: InChI=1S/C49H56N7O11PS/c1-54(2)31-51-48-52-45-42(46(57)53-48)50-32-55(45)47-44(63-28-27-60-3)43(67-68-56-26-12-17-39(56)41(66-68)30-69(58,59)38-15-10-7-11-16-38)40(65-47)29-64-49(33-13-8-6-9-14-33,34-18-22-36(61-4)23-19-34)35-20-24-37(62-5)25-21-35/h6-11,13-16,18-25,31-32,39-41,43-44,47H,12,17,26-30H2,1-5H3,(H,52,53,57)/t39-,40+,41+,43+,44+,47+,68+/m0/s1
Synonyms: 5'-O-DMT-2'-O-MOE-G(dmf)-3'-(L)-PSM-Phosphoramidite

DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-(L)-PSM-Phosphoramidite

Description: DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-(L)-PSM-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified cytidine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as antisense technology, RNA interference (RNAi), and gene regulation research.
CAT: BRP-00584
CAS: 2379296-21-4
MF: C53H57N4O12PS
MF: 1005.09
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: UUMRAIRUULBYGT-PRACXZEXSA-N
CanonicalSMILES: O=C1N=C(NC(=O)C=2C=CC=CC2)C(=CN1C3OC(COC(C=4C=CC=CC4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)C(OP7OC(CS(=O)(=O)C=8C=CC=CC8)C9N7CCC9)C3OCCOC)C
IUPAC Name: N-(1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2-methoxyethoxy)-4-(((1S,3S,3aS)-3-((phenylsulfonyl)methyl)tetrahydro-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl)oxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
InChI: InChI=1S/C53H57N4O12PS/c1-36-33-56(52(59)55-49(36)54-50(58)37-15-8-5-9-16-37)51-48(65-32-31-62-2)47(69-70-57-30-14-21-44(57)46(68-70)35-71(60,61)43-19-12-7-13-20-43)45(67-51)34-66-53(38-17-10-6-11-18-38,39-22-26-41(63-3)27-23-39)40-24-28-42(64-4)29-25-40/h5-13,15-20,22-29,33,44-48,51H,14,21,30-32,34-35H2,1-4H3,(H,54,55,58,59)/t44-,45+,46+,47+,48+,51+,70+/m0/s1
Synonyms: Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-3'-O-[(1S,3S,3aS)-tetrahydro-3-[(phenylsulfonyl)methyl]-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaphosphol-1-yl]-

DMTr-2'-O-(Methyl palmitate)-rU-3'-CE-Phosphoramidite

Description: DMTr-2'-O-(Methyl palmitate)-rU-3'-CE-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified uridine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as RNA interference (RNAi), gene silencing, and nucleic acid therapeutics.
CAT: BRP-00585
CAS: 2642320-25-8
MF: C56H79N4O11P
MF: 1015.24
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: NWFCOAVWTXVSHI-GWCNJYPESA-N
CanonicalSMILES: N#CCCOP(OC1C(OC(N2C=CC(=O)NC2=O)C1OCCCCCCCCCCCCCCCC(=O)OC)COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)N(C(C)C)C(C)C
IUPAC Name: methyl 16-(((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(((2-cyanoethoxy)(diisopropylamino)phosphaneyl)oxy)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)oxy)hexadecanoate
InChI: InChI=1S/C56H79N4O11P/c1-42(2)60(43(3)4)72(69-40-24-37-57)71-52-49(41-68-56(44-25-20-19-21-26-44,45-28-32-47(64-5)33-29-45)46-30-34-48(65-6)35-31-46)70-54(59-38-36-50(61)58-55(59)63)53(52)67-39-23-18-16-14-12-10-8-9-11-13-15-17-22-27-51(62)66-7/h19-21,25-26,28-36,38,42-43,49,52-54H,8-18,22-24,27,39-41H2,1-7H3,(H,58,61,63)/t49-,52-,53-,54-,72?/m1/s1
Synonyms: Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(16-methoxy-16-oxohexadecyl)-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]

DMTr-2'-O-C16-rU-3'-CE-Phosphoramidite

Description: DMTr-2'-O-C16-rU-3'-CE-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified uridine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as RNA interference (RNAi), gene silencing, and nucleic acid therapeutics.
CAT: BRP-00586
CAS: 2382942-83-6
MF: C55H79N4O9P
MF: 971.21
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: MGKJVGDGCZEJKK-KSNSTLKFSA-N
CanonicalSMILES: CCCCCCCCCCCCCCCCOC1C(C(OC1N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N
IUPAC Name: 3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-hexadecoxyoxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
InChI: InChI=1S/C55H79N4O9P/c1-8-9-10-11-12-13-14-15-16-17-18-19-20-24-39-64-52-51(68-69(66-40-25-37-56)59(42(2)3)43(4)5)49(67-53(52)58-38-36-50(60)57-54(58)61)41-65-55(44-26-22-21-23-27-44,45-28-32-47(62-6)33-29-45)46-30-34-48(63-7)35-31-46/h21-23,26-36,38,42-43,49,51-53H,8-20,24-25,39-41H2,1-7H3,(H,57,60,61)/t49-,51-,52-,53-,69?/m1/s1
Synonyms: O-C16-rU-3'-CE-Phosphoramidite; 2'-O-C16-U phosphoramidite; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-hexadecyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]

DMTr-2'-O-C16-rC(Ac)-3'-CE-Phosphoramidite

Description: DMTr-2'-O-C16-rC(Ac)-3'-CE-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified cytidine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as RNA interference (RNAi), gene silencing, and nucleic acid therapeutics.
CAT: BRP-00587
CAS: 2382942-38-1
MF: C57H82N5O9P
MF: 1012.28
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: NMBMTBHXQJMTLO-LCKVQZKFSA-N
CanonicalSMILES: CCCCCCCCCCCCCCCCOC1C(C(OC1N2C=CC(=NC2=O)NC(=O)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N
IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-hexadecoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
InChI: InChI=1S/C57H82N5O9P/c1-9-10-11-12-13-14-15-16-17-18-19-20-21-25-40-67-54-53(71-72(69-41-26-38-58)62(43(2)3)44(4)5)51(70-55(54)61-39-37-52(59-45(6)63)60-56(61)64)42-68-57(46-27-23-22-24-28-46,47-29-33-49(65-7)34-30-47)48-31-35-50(66-8)36-32-48/h22-24,27-37,39,43-44,51,53-55H,9-21,25-26,40-42H2,1-8H3,(H,59,60,63,64)/t51-,53-,54-,55-,72?/m1/s1
Synonyms: 2'-O-C16-C(Ac) phosphoramidite; Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-hexadecyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]

DMTr-2'-O-C16-rG(iBu)-3'-CE-Phosphoramidite

Description: DMTr-2'-O-C16-rG(iBu)-3'-CE-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified guanosine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as RNA interference (RNAi), gene silencing, and nucleic acid therapeutics.
CAT: BRP-00588
CAS: 2382942-32-5
MF: C60H86N7O9P
MF: 1080.36
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: UOYPBRBOXKOJLE-ZGTMVWBUSA-N
CanonicalSMILES: CCCCCCCCCCCCCCCCOC1C(C(OC1N2C=NC3=C2N=C(NC3=O)NC(=O)C(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OP(N(C(C)C)C(C)C)OCCC#N
IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-hexadecoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C60H86N7O9P/c1-10-11-12-13-14-15-16-17-18-19-20-21-22-26-39-72-54-53(76-77(74-40-27-38-61)67(44(4)5)45(6)7)51(75-58(54)66-42-62-52-55(66)63-59(65-57(52)69)64-56(68)43(2)3)41-73-60(46-28-24-23-25-29-46,47-30-34-49(70-8)35-31-47)48-32-36-50(71-9)37-33-48/h23-25,28-37,42-45,51,53-54,58H,10-22,26-27,39-41H2,1-9H3,(H2,63,64,65,68,69)/t51-,53-,54-,58-,77?/m1/s1
Synonyms: N2-iBu-5'-O-DMTr-2'-O-hexadecanyl guanosine 3'-CED phosphoramidite; 2'-O-C16-G(iBu) phosphoramidite; Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-hexadecyl-N-(2-methyl-1-oxopropyl)-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]

DMTr-2'-ara-OAc-U-3'-CE-Phosphoramidite

Description: DMTr-2'-ara-OAc-U-3'-CE-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified uridine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as RNA interference (RNAi), gene silencing, and nucleic acid therapeutics.
CAT: BRP-00589
CAS: 173099-63-3
MF: C41H49N4O10P
MF: 788.83
Purity: ≥98%
Appearance: Off-white solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: XQPRAGYYSCIUMN-KEZDHIJLSA-N
Solubility: Soluble in Acetonitrile, DMF
CanonicalSMILES: N#CCCOP(OC1C(OC(N2C=CC(=O)NC2=O)C1OC(=O)C)COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)N(C(C)C)C(C)C
IUPAC Name: (2R,3S,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(((2-cyanoethoxy)(diisopropylamino)phosphaneyl)oxy)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl acetate
InChI: InChI=1S/C41H49N4O10P/c1-27(2)45(28(3)4)56(52-25-11-23-42)55-37-35(54-39(38(37)53-29(5)46)44-24-22-36(47)43-40(44)48)26-51-41(30-12-9-8-10-13-30,31-14-18-33(49-6)19-15-31)32-16-20-34(50-7)21-17-32/h8-10,12-22,24,27-28,35,37-39H,11,25-26H2,1-7H3,(H,43,47,48)/t35-,37-,38+,39-,56?/m1/s1
Synonyms: 5'-O-(4,4'-dimethoxytrityl)-2'-O-acetyl-arabinouridine-3'-[(2-cyanoethyl)-(N,N-diisopropropyl)]-Phosphoramidite; 5'-O-DMTr-2'-ara-OAc-U-3'-CE-Phosphoramidite; 1-[2-O-Acetyl-5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-β-D-arabinofuranosyl]-2,4(1H,3H)-pyrimidinedione; ANA 2'-OAc U amidite; Ara-U-amidite

DMTr-2'-ara-OAc-G(iBu)-3'-CE-Phosphoramidite

Description: DMTr-2'-ara-OAc-G(iBu)-3'-CE-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified guanosine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as RNA interference (RNAi), gene silencing, and nucleic acid therapeutics.
CAT: BRP-00590
CAS: 160684-51-5
MF: C46H56N7O10P
MF: 897.38
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: QLYLXXFVZIYNFL-CMURLGQCSA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OP(N(C(C)C)C(C)C)OCCC#N)OC(=O)C
IUPAC Name: [(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-3-yl] acetate
InChI: InChI=1S/C46H56N7O10P/c1-28(2)42(55)50-45-49-41-38(43(56)51-45)48-27-52(41)44-40(61-31(7)54)39(63-64(60-25-13-24-47)53(29(3)4)30(5)6)37(62-44)26-59-46(32-14-11-10-12-15-32,33-16-20-35(57-8)21-17-33)34-18-22-36(58-9)23-19-34/h10-12,14-23,27-30,37,39-40,44H,13,25-26H2,1-9H3,(H2,49,50,51,55,56)/t37-,39-,40+,44-,64?/m1/s1
Synonyms: N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-O-acetyl-arabinoguanosine-3'-[(2-cyanoethyl)-(N,N-diisopropropyl)]-Phosphoramidite; 5'-O-DMTr-2'-ara-OAc-G(ibu)-3'-CE-Phosphoramidite; N-[9-[2-O-Acetyl-5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-β-D-arabinofuranosyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-2-methylpropanamide; Phosphoramidous acid, bis(1-methylethyl)-, mono(2-cyanoethyl) ester, ester with N-[9-[2-O-acetyl-5-O-[bis(4-methoxyphenyl)phenylmethyl]-β-D-arabinofuranosyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-2-methylpropanamide; Ara-G-amidite

DMTr-2'-ara-OAc-A(Bz)-3'-CE-Phosphoramidite

Description: DMTr-2'-ara-OAc-A(Bz)-3'-CE-Phosphoramidite is utilized in oligonucleotide synthesis. It is employed to introduce modified adenosine residues with altered chemical properties into nucleic acid sequences, suitable for applications such as RNA interference (RNAi), gene silencing, and nucleic acid therapeutics.
CAT: BRP-00591
CAS: 2756253-85-5
MF: C49H54N7O9P
MF: 915.98
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: QLQIHUMYIFDYEK-ASTLELISSA-N
CanonicalSMILES: N#CCCOP(OC1C(OC(N2C=NC=3C(=NC=NC32)NC(=O)C=4C=CC=CC4)C1OC(=O)C)COC(C=5C=CC=CC5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)N(C(C)C)C(C)C
IUPAC Name: (2R,3S,4R,5R)-2-(6-benzamido-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(((2-cyanoethoxy)(diisopropylamino)phosphaneyl)oxy)tetrahydrofuran-3-yl acetate
InChI: InChI=1S/C49H54N7O9P/c1-32(2)56(33(3)4)66(62-28-14-27-50)65-43-41(29-61-49(36-17-12-9-13-18-36,37-19-23-39(59-6)24-20-37)38-21-25-40(60-7)26-22-38)64-48(44(43)63-34(5)57)55-31-53-42-45(51-30-52-46(42)55)54-47(58)35-15-10-8-11-16-35/h8-13,15-26,30-33,41,43-44,48H,14,28-29H2,1-7H3,(H,51,52,54,58)/t41-,43-,44+,48-,66?/m1/s1
Synonyms: 5'-O-DMTr-2'-ara-OAc-A(Bz)-3'-CE-Phosphoramidite; N6-benzoyl-(5'-O-(4,4'-dimethoxytrityl)-2'-O-acetyl-arabinoadenosine-3'-[(2-cyanoethyl)-(N,N-diisopropropyl)]-Phosphoramidite; Benzamide, N-[9-[2-O-acetyl-5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-β-D-arabinofuranosyl]-9H-purin-6-yl]-; Adenosine Arabinoside

3'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-5'-CE-Phosphoramidite

Description: 3'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-5'-CE-Phosphoramidite is a specialized nucleotide used in oligonucleotide synthesis. It contains a 3'-dimethoxytrityl (DMTr) protecting group on the 3' hydroxyl, a 2'-O-methoxyethyl (MOE) modification at the 2' position of the ribose sugar, a methyl (Me) modification at the 5' position of the cytosine base, and a benzoyl (Bz) protecting group on the cytosine amino group. Additionally, it features a 5'-cyanoethyl (CE) phosphoramidite functionality for controlled addition during synthesis. This compound facilitates stable and precise synthesis of customized oligonucleotides, useful for various molecular biology research applications.
CAT: BRP-00592
CAS: 3025999-57-6
MF: C50H60N5O10P
MF: 922.03
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: LGQSXYUXQBROPP-GICDFOIUSA-N
CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C(C(C(O3)COP(N(C(C)C)C(C)C)OCCC#N)OC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OCCOC
IUPAC Name: N-[1-[(2R,3R,4R,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-5-[[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxymethyl]-3-(2-methoxyethoxy)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
InChI: InChI=1S/C50H60N5O10P/c1-34(2)55(35(3)4)66(62-29-15-28-51)63-33-43-44(65-50(38-18-13-10-14-19-38,39-20-24-41(59-7)25-21-39)40-22-26-42(60-8)27-23-40)45(61-31-30-58-6)48(64-43)54-32-36(5)46(53-49(54)57)52-47(56)37-16-11-9-12-17-37/h9-14,16-27,32,34-35,43-45,48H,15,29-31,33H2,1-8H3,(H,52,53,56,57)/t43-,44-,45-,48-,66?/m1/s1
Synonyms: Rev 2'-O-MOE-5MeC(Bz)-5'-amidite; ((2R,3R,4R,5R)-5-(4-benzamido-5-methyl-2-oxopyrimidin-1(2H)-yl)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-4-(2-methoxyethoxy)tetrahydrofuran-2-yl)methyl (2-cyanoethyl) diisopropylphosphoramidite

3'-O-DMTr-2'-O-MOE-rA(Bz)-5'-CE-Phosphoramidite

Description: 3'-O-DMTr-2'-O-MOE-rA(Bz)-5'-CE-Phosphoramidite is a specialized nucleotide derivative used in oligonucleotide synthesis. It features a 3'-dimethoxytrityl (DMTr) protecting group on the 3' hydroxyl, a 2'-O-methoxyethyl (MOE) modification at the 2' position of the ribose sugar, and a benzoyl (Bz) protecting group on the adenine (A) base. Additionally, it contains a 5'-cyanoethyl (CE) phosphoramidite functionality, enabling controlled addition during synthesis. This compound facilitates stable and precise synthesis of customized oligonucleotides, making it valuable for molecular biology research applications.
CAT: BRP-00593
CAS: 3025999-68-9
MF: C50H58N7O9P
MF: 932.03
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: XNXRGROTYZFYBK-HDMAWCRFSA-N
CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)OCCOC)OC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC
IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-5-[[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxymethyl]-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide
InChI: InChI=1S/C50H58N7O9P/c1-34(2)57(35(3)4)67(63-28-14-27-51)64-31-42-44(66-50(37-17-12-9-13-18-37,38-19-23-40(60-6)24-20-38)39-21-25-41(61-7)26-22-39)45(62-30-29-59-5)49(65-42)56-33-54-43-46(52-32-53-47(43)56)55-48(58)36-15-10-8-11-16-36/h8-13,15-26,32-35,42,44-45,49H,14,28-31H2,1-7H3,(H,52,53,55,58)/t42-,44-,45-,49-,67?/m1/s1
Synonyms: Rev 2'-O-MOE-A(Bz)-5'-amidite; ((2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-4-(2-methoxyethoxy)tetrahydrofuran-2-yl)methyl (2-cyanoethyl) diisopropylphosphoramidite

3'-O-DMTr-2'-O-MOE-rG(iBu)-5'-CE-Phosphoramidite

Description: 3'-O-DMTr-2'-O-MOE-rG(iBu)-5'-CE-Phosphoramidite is a specialized nucleotide derivative used in oligonucleotide synthesis. It features a 3'-dimethoxytrityl (DMTr) protecting group on the 3' hydroxyl, a 2'-O-methoxyethyl (MOE) modification at the 2' position of the ribose sugar, and a benzoyl (Bz) protecting group on the adenine (A) base. Additionally, it contains a 5'-cyanoethyl (CE) phosphoramidite functionality, enabling controlled addition during synthesis. This compound facilitates stable and precise synthesis of customized oligonucleotides, making it valuable for molecular biology research applications.
CAT: BRP-00594
CAS: 725223-44-9
MF: C47H60N7O10P
MF: 914.00
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: YLDSIMQFLQLTEA-SBCRAQIVSA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(N(C(C)C)C(C)C)OCCC#N)OC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OCCOC
IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-5-[[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxymethyl]-3-(2-methoxyethoxy)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C47H60N7O10P/c1-30(2)43(55)51-46-50-42-39(44(56)52-46)49-29-53(42)45-41(60-27-26-57-7)40(38(63-45)28-62-65(61-25-13-24-48)54(31(3)4)32(5)6)64-47(33-14-11-10-12-15-33,34-16-20-36(58-8)21-17-34)35-18-22-37(59-9)23-19-35/h10-12,14-23,29-32,38,40-41,45H,13,25-28H2,1-9H3,(H2,50,51,52,55,56)/t38-,40-,41-,45-,65?/m1/s1
Synonyms: Rev 2'-O-MOE-G(iBu)-5'-amidite; Guanosine, 3'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 5'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]

U PMO Monomer

Description: U PMO Monomer is a monomer used in the synthesis of peptide-conjugated morpholino oligomers (PMO). PMOs are synthetic nucleic acid analogs designed for antisense therapy and gene expression modulation. The ''U'' designation indicates that the monomer is based on uracil, a nucleobase commonly used in nucleic acid analogs. These monomers are incorporated into PMOs to specifically target and bind complementary RNA sequences, thereby interfering with gene expression or splicing mechanisms.
CAT: BRP-00595
CAS: 2388517-98-2
MF: C30H32ClN4O5P
MF: 595.03
Purity: ≥98%
Appearance: White to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
Density: 1.320±0.06 g/cm3
InChIKey: GCLNBTZDWZLIOP-JOLGRYLWSA-N
CanonicalSMILES: CN(C)P(=O)(OCC1CN(CC(O1)N2C=CC(=O)NC2=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5)Cl
IUPAC Name: 1-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C30H32ClN4O5P/c1-33(2)41(31,38)39-22-26-20-34(21-28(40-26)35-19-18-27(36)32-29(35)37)30(23-12-6-3-7-13-23,24-14-8-4-9-15-24)25-16-10-5-11-17-25/h3-19,26,28H,20-22H2,1-2H3,(H,32,36,37)/t26-,28+,41?/m0/s1
Synonyms: ((2S,6R)-6-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate; [(2S,6R)-6-(3,4-Dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-4-(triphenylmethyl)-2-morpholinyl]methyl N,N-dimethylphosphoramidochloridate; Morpholino U

O6-(p-tolyl pivalate)-N2-PhAc protected G PMO Monomer

Description: O6-(p-tolyl pivalate)-N2-PhAc protected G PMO Monomer is a modified guanosine (G) monomer used in the synthesis of peptide-conjugated morpholino oligomers (PMO). It features a pivaloyloxymethyl (p-tolyl pivalate) group at the O6 position and a phenylacetyl (PhAc) group at the N2 position, providing protection to the guanine base during oligomer synthesis. PMOs are synthetic nucleic acid analogs designed for antisense therapy and gene expression modulation. These monomers are incorporated into PMOs to specifically target and bind complementary RNA sequences, thereby interfering with gene expression or splicing mechanisms.
CAT: BRP-00596
CAS: 1155309-89-9
MF: C51H53ClN7O7P
MF: 942.44
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
Density: 1.29±0.1 g/cm3
InChIKey: TXKNJPOHRYJGGF-UHFFFAOYSA-N
CanonicalSMILES: CC(C)(C)C(=O)OC1=CC=C(C=C1)COC2=NC(=NC3=C2N=CN3C4CN(CC(O4)COP(=O)(N(C)C)Cl)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)NC(=O)CC8=CC=CC=C8
IUPAC Name: [4-[[9-[6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-2-[(2-phenylacetyl)amino]purin-6-yl]oxymethyl]phenyl] 2,2-dimethylpropanoate
InChI: InChI=1S/C51H53ClN7O7P/c1-50(2,3)48(61)66-41-28-26-37(27-29-41)33-63-47-45-46(55-49(56-47)54-43(60)30-36-18-10-6-11-19-36)59(35-53-45)44-32-58(31-42(65-44)34-64-67(52,62)57(4)5)51(38-20-12-7-13-21-38,39-22-14-8-15-23-39)40-24-16-9-17-25-40/h6-29,35,42,44H,30-34H2,1-5H3,(H,54,55,56,60)
Synonyms: Propanoic acid, 2,2-dimethyl-, 4-[[[9-[6-[[[chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl ester; Activated DPG Subunit; 4-[[[9-[6-[[[Chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl 2,2-dimethylpropanoate; PMO G(PhAc) Phosphoramidite

4-(((9-((2R,6S)-6-(((Chloro(dimethylamino)phosphoryl)oxy)methyl)-4-tritylmorpholin-2-yl)-2-(2-phenylacetamido)-9H-purin-6-yl)oxy)methyl)phenyl pivalate

Description: 4-(((9-((2R,6S)-6-(((Chloro(dimethylamino)phosphoryl)oxy)methyl)-4-tritylmorpholin-2-yl)-2-(2-phenylacetamido)-9H-purin-6-yl)oxy)methyl)phenyl pivalate is a complex molecular structure used in oligonucleotide synthesis. This structure likely serves as a protecting group or linker in the synthesis of nucleic acid analogs, enabling the controlled assembly of oligonucleotide sequences. The compound's design incorporates functionalities for efficient coupling reactions and protection of sensitive chemical groups during solid-phase synthesis.
CAT: BRP-00597
CAS: 1044241-66-8
MF: C51H53ClN7O7P
MF: 942.44
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
Density: 1.29±0.1 g/cm3
InChIKey: TXKNJPOHRYJGGF-OHCUOHFYSA-N
CanonicalSMILES: CC(C)(C)C(=O)OC1=CC=C(C=C1)COC2=NC(=NC3=C2N=CN3C4CN(CC(O4)COP(=O)(N(C)C)Cl)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)NC(=O)CC8=CC=CC=C8
IUPAC Name: [4-[[9-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-2-[(2-phenylacetyl)amino]purin-6-yl]oxymethyl]phenyl] 2,2-dimethylpropanoate
InChI: InChI=1S/C51H53ClN7O7P/c1-50(2,3)48(61)66-41-28-26-37(27-29-41)33-63-47-45-46(55-49(56-47)54-43(60)30-36-18-10-6-11-19-36)59(35-53-45)44-32-58(31-42(65-44)34-64-67(52,62)57(4)5)51(38-20-12-7-13-21-38,39-22-14-8-15-23-39)40-24-16-9-17-25-40/h6-29,35,42,44H,30-34H2,1-5H3,(H,54,55,56,60)/t42-,44+,67?/m0/s1
Synonyms: Propanoic acid, 2,2-dimethyl-, 4-[[[9-[(2R,6S)-6-[[[chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl ester; 4-[[[9-[(2R,6S)-6-[[[Chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl 2,2-dimethylpropanoate; O6-(p-tolyl pivalate)-N2-PhAc protected G PMO Monomer

DMTr-2'-O-4'-C-ethylene-rU-3'-CE-Phosphoramidite

Description: DMTr-2'-O-4'-C-ethylene-rU-3'-CE-Phosphoramidite, utilized in oligonucleotide synthesis, exhibits increased stability and binding properties owing to the incorporation of an ethylene linker at the 2'-O and 4'-C positions of uridine (rU). The presence of a cyanoethyl (CE) group at the 3'-end facilitates efficient coupling reactions during solid-phase synthesis. It is particularly useful in the generation of modified RNA molecules for various biological applications, such as RNA interference (RNAi) and antisense therapy.
CAT: BRP-00598
CAS: 287737-49-9
MF: C41H49N4O9P
MF: 772.84
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: WGXJDXATSZPKMD-JOFAAVELSA-N
CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C2C(OC1(CCO2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)N6C=CC(=O)NC6=O
IUPAC Name: 3-[[(1R,5R,7R,8S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-(2,4-dioxopyrimidin-1-yl)-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
InChI: InChI=1S/C41H49N4O9P/c1-28(2)45(29(3)4)55(52-25-10-23-42)54-37-36-38(44-24-21-35(46)43-39(44)47)53-40(37,22-26-50-36)27-51-41(30-11-8-7-9-12-30,31-13-17-33(48-5)18-14-31)32-15-19-34(49-6)20-16-32/h7-9,11-21,24,28-29,36-38H,10,22,25-27H2,1-6H3,(H,43,46,47)/t36-,37+,38-,40-,55?/m1/s1
Synonyms: 2,4(1H,3H)-Pyrimidinedione, 1-[2,6-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-; 1-[2,6-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-2,4(1H,3H)-pyrimidinedione; ENA-U Phosphoramidite

DMTr-2'-O-4'-C-ethylene-rC(Bz)-3'-CE-Phosphoramidite

Description: DMTr-2'-O-4'-C-ethylene-rC(Bz)-3'-CE-Phosphoramidite, employed in oligonucleotide synthesis, features an ethylene linker at the 2'-O and 4'-C positions of cytidine (rC), along with benzoyl (Bz) protection on the cytosine amino group. The cyanoethyl (CE) group at the 3'-end facilitates efficient coupling reactions during solid-phase synthesis. This modified nucleotide finds application in the creation of RNA sequences with enhanced stability and binding affinity, suitable for gene silencing studies and RNA-based therapeutics.
CAT: BRP-00599
CAS: 287737-36-4
MF: C48H54N5O9P
MF: 875.96
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: IZEZSKXQKDNBEX-HAUVADMLSA-N
CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C2C(OC1(CCO2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)N6C=CC(=NC6=O)NC(=O)C7=CC=CC=C7
IUPAC Name: N-[1-[(1R,5R,7R,8S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-8-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2,6-dioxabicyclo[3.2.1]octan-7-yl]-2-oxopyrimidin-4-yl]benzamide
InChI: InChI=1S/C48H54N5O9P/c1-33(2)53(34(3)4)63(60-30-13-28-49)62-43-42-45(52-29-26-41(51-46(52)55)50-44(54)35-14-9-7-10-15-35)61-47(43,27-31-58-42)32-59-48(36-16-11-8-12-17-36,37-18-22-39(56-5)23-19-37)38-20-24-40(57-6)25-21-38/h7-12,14-26,29,33-34,42-43,45H,13,27,30-32H2,1-6H3,(H,50,51,54,55)/t42-,43+,45-,47-,63?/m1/s1
Synonyms: N-[1-[2,6-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]benzamide; (1R,5R,7R,8S)-7-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-2,6-dioxabicyclo[3.2.1]octan-8-yl (2-cyanoethyl) diisopropylphosphoramidite; ENA-C(Bz) Phosphoramidite

DMTr-2'-O-4'-C-ethylene-rA(Bz)-3'-CE-Phosphoramidite

Description: DMTr-2'-O-4'-C-ethylene-rA(Bz)-3'-CE-Phosphoramidite, used in oligonucleotide synthesis, contains an ethylene linker at the 2'-O and 4'-C positions of adenosine (rA), with benzoyl (Bz) protection on the adenine amino group. The cyanoethyl (CE) group at the 3'-end facilitates efficient coupling reactions during solid-phase synthesis. It is employed in the construction of RNA sequences with augmented stability and binding affinity, suitable for various research applications including RNA-targeted therapy and gene expression modulation.
CAT: BRP-00600
CAS: 287737-45-5
MF: C49H54N7O8P
MF: 899.99
Purity: ≥98%
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: IUGJZRODLODQAN-QLRWGQFGSA-N
CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C2C(OC1(CCO2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)N6C=NC7=C(N=CN=C76)NC(=O)C8=CC=CC=C8
IUPAC Name: N-[9-[(1R,5R,7R,8S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-8-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2,6-dioxabicyclo[3.2.1]octan-7-yl]purin-6-yl]benzamide
InChI: InChI=1S/C49H54N7O8P/c1-33(2)56(34(3)4)65(62-28-13-27-50)64-43-42-47(55-32-53-41-44(51-31-52-45(41)55)54-46(57)35-14-9-7-10-15-35)63-48(43,26-29-60-42)30-61-49(36-16-11-8-12-17-36,37-18-22-39(58-5)23-19-37)38-20-24-40(59-6)25-21-38/h7-12,14-25,31-34,42-43,47H,13,26,28-30H2,1-6H3,(H,51,52,54,57)/t42-,43+,47-,48-,65?/m1/s1
Synonyms: Benzamide, N-[9-[2,6-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-9H-purin-6-yl]-; ENA-A(bz) Phosphoramidite; N-[9-[2,6-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-9H-purin-6-yl]benzamide
* Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket